Vilanterol / Umeclidinium (25/62.5 mcg) Clinical Trials

1 actively recruiting trial

Also known as: ANORO

Pipeline

Phase 4: 1

Top Sponsors

National Institute of Respiratory Diseases, Mexico1

Indications

Pollution Related Respiratory Disorder1
COPD Bronchitis1
COPD1

Other1 trial

Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.